25 results
424B3
CRVO
CervoMed Inc
6 Jun 24
Prospectus supplement
6:03am
may make the acquisition of the Company, a proxy contest, or the nomination of a director candidate by a stockholder more difficult than such actions … enable our board of directors to discourage an attempt to obtain control of the Company by means of a merger, tender offer, proxy contest
8-K
EX-10.1
CRVO
CervoMed Inc
16 Dec 22
Diffusion Pharmaceuticals Announces Agreement with LifeSci Special Opportunities
5:10pm
consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:
Withdrawal of LifeSci Proxy Contest
DEFA14A
EX-99.1
xwyqulvai4vwdx
5 Dec 22
Additional proxy soliciting materials
9:59pm
8-K
EX-99.1
syym7
5 Dec 22
Diffusion has a highly engaged and independent board that possesses the right skills and experience to execute the strategic review process
9:58pm
DEFC14A
6c8rtqpzms 9eef7sazq
5 Dec 22
Proxy in contested solicitation
5:12pm
DEFA14A
yda64rf15 7fprn5k
1 Dec 22
Additional proxy soliciting materials
4:34pm
8-K
2eqwhesrmys63m8afhik
1 Dec 22
Other Events
4:34pm
PRER14A
4s3jc x0mrs
28 Nov 22
Preliminary revised proxy
5:17pm
PREC14A
of2gh
18 Nov 22
Preliminary proxy with contested solicitation
5:08pm
8-K
EX-99.1
uqk7au0t4n4
18 Nov 22
Diffusion Pharmaceuticals Sees Significant Progress in its Strategic Review Process
4:40pm
DEFA14A
EX-99.1
c2j rrwgeewtj6a9qv
14 Nov 22
Additional proxy soliciting materials
7:41am
8-K
EX-99.1
s8j7rkv9q p7
14 Nov 22
Diffusion Pharmaceuticals Sees Significant Progress in its Strategic Review Process
7:40am